928 related articles for article (PubMed ID: 21923281)
1. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
3. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
4. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
5. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
6. Uptake and adherence to long-acting reversible contraception post-abortion.
Rose SB; Lawton BA; Brown SA
Contraception; 2010 Oct; 82(4):345-53. PubMed ID: 20851228
[TBL] [Abstract][Full Text] [Related]
7. Impact of long-acting reversible contraception on return for repeat abortion.
Rose SB; Lawton BA
Am J Obstet Gynecol; 2012 Jan; 206(1):37.e1-6. PubMed ID: 21944222
[TBL] [Abstract][Full Text] [Related]
8. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
Cremer M; Ditzian L; April A; Peralta E; Klausner D; Podolsky R; Dierking E
J Womens Health (Larchmt); 2011 Nov; 20(11):1751-6. PubMed ID: 21823919
[TBL] [Abstract][Full Text] [Related]
9. Long-acting, reversible and permanent methods of contraception: insight into women's choice of method.
Kane R; Irving G; Brown S; Parkes N; Walling M; Killick S
Qual Prim Care; 2009; 17(2):107-14. PubMed ID: 19416603
[TBL] [Abstract][Full Text] [Related]
10. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
Rose SB; Garrett SM
J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
[TBL] [Abstract][Full Text] [Related]
11. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
[TBL] [Abstract][Full Text] [Related]
12. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
13. The contraceptive practices of women seeking termination of pregnancy in an Auckland clinic.
Young LK; Farquhar CM; McCowan LM; Roberts HE; Taylor J
N Z Med J; 1994 May; 107(978):189-92. PubMed ID: 8196861
[TBL] [Abstract][Full Text] [Related]
14. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
[TBL] [Abstract][Full Text] [Related]
15. General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK.
Middleton AJ; Naish J; Singer N
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):311-8. PubMed ID: 21585243
[TBL] [Abstract][Full Text] [Related]
16. Long-acting reversible contraception.
Peck SA
Nurs Womens Health; 2013 Oct; 17(5):431-5. PubMed ID: 24138662
[TBL] [Abstract][Full Text] [Related]
17. Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.
Secura G
Minerva Ginecol; 2013 Jun; 65(3):271-7. PubMed ID: 23689169
[TBL] [Abstract][Full Text] [Related]
18. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
19. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
20. Profile of long-acting reversible contraception users in Europe.
Haimovich S
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
